Free shipping on all treatments. See treatments
Oana Health · Facial hair, two layers

The cream slows growth.
The pill blocks the chin hair cause.

For unwanted facial hair, a provider can review whether eflornithine, spironolactone, or both are appropriate for your hormonal pattern. One intake — your provider matches the plan to your case.

Topical + oral optionsOnline provider reviewFree discreet shipping
EflornithineAll AgesSpironolactoneAge <46
About 5 minutes · Provider chooses what is appropriate
Confident woman after starting a facial hair treatment plan
A patient said"Tweezing went from daily to once a week."Mira, 38 · verified patient
As trusted in
GoopFortuneFox News
Two products, one plan

Your provider picks the layer — or both.

Each product addresses a different point in the hair cycle. The right plan depends on what your hair is doing and what you have already tried.

No. 01 · The creamAll Ages

Eflornithine 12%

A topical that slows new growth at the follicle — the same active ingredient as Vaniqa. Faster visible surface change. Apply twice daily.

$119/monthTwice dailyTopical
Review cream options
No. 02 · The pillAge <46

Spironolactone

An oral anti-androgen that addresses the hormonal signal driving facial hair. Slower to land, but works at the cause. Daily tablet.

$83/quarterDailyOral
Review pill options
What progress looks like

Surface change first. Cause change next.

For most women on a combined plan, the cream lands faster while the pill builds underneath.

01Weeks 4–8

Cream begins to slow regrowth

Days between tweezing or shaving start to stretch out. Hair feels finer at the surface.

02Months 2–4

Hormonal signal quiets

If on spironolactone, the hormonal driver behind the hair gradually softens. Cycle-pattern hair becomes less aggressive.

03Months 4–6+

Slower & finer regrowth holds

Removal needed less often. The combination keeps both layers consistent. Continued use is what holds the result.

Real results

Less time at the mirror. Less time apologizing for hair.

Reviews from women who started a facial hair plan online with Oana.

"The cream gave me visible change first. Adding the pill a few months later is what kept it consistent through every cycle. I tweeze maybe once a week now."

Mira K., 38Eflornithine + spironolactone · 6 months in

"I didn't want a pill, so my provider started me on the cream alone. Four months in, the chin hair is finer and slower. I'll consider adding spiro later if I want more."

Erin J., 41Eflornithine only · 4 months in

A private online process

Three steps. No waiting room.

Tell us where the hair is showing up. A licensed provider reviews everything before any prescription is written.

Step 01

Short online intake

Share where the hair is, what cycle pattern you see, and what you have tried. Takes about 5 minutes.

Step 02

Provider review

A licensed provider reviews your history and matches you to eflornithine, spironolactone, or both — only what is appropriate.

Step 03

Discreet delivery

Your prescription ships free in plain packaging. Cancel anytime, refills are automatic.

Common questions

Everything you might want to know.

Eflornithine is a topical cream that works at the follicle to slow how fast new facial hair grows back. Spironolactone is an oral anti-androgen that quiets the hormonal signal driving the hair in the first place. They address different layers of the same problem, which is why some women benefit from both.

Ready when you are

Two products. One plan, matched to you.

Start a short online visit. A licensed provider reviews your history and matches you to the right combination if it is appropriate.

EflornithineAll AgesSpironolactoneAge <46
Free shipping FSA / HSA eligible Cancel anytime

*Prescription treatment if appropriate. Eflornithine slows new hair growth and does not remove existing hair; same active ingredient as Vaniqa. Spironolactone should not be used during pregnancy and is typically prescribed alongside reliable contraception. The decision to prescribe is at the discretion of your Oana-affiliated provider. Not all patients are candidates. Individual results vary.